Protalix BioTherapeutics, Inc. (PLX)

Protalix BioTherapeutics Revenue

In the year 2025, Protalix BioTherapeutics had annual revenue of $52.74M, down -1.23%. Protalix BioTherapeutics had revenue of $9.12M in the quarter ending December 31, 2025, a decrease of -49.93%.

• Revenue (ttm): $52.74M
• Revenue Growth: -19.47%
• P/S Ratio: 3.27
• Revenue / Employee: $233,381
• Employees: 226
• Market Cap: 175.24M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	52.74M	-655.00K	-1.23%
Dec 31, 2024	53.40M	-12.10M	-18.47%
Dec 31, 2023	65.49M	17.86M	37.48%
Dec 31, 2022	47.64M	9.29M	24.22%
Dec 31, 2021	38.35M	-24.55M	-39.03%
Dec 31, 2020	62.90M	8.21M	15.00%
Dec 31, 2019	54.69M	20.45M	59.73%
Dec 31, 2018	34.24M	13.16M	62.44%
Dec 31, 2017	21.08M	11.88M	129.13%
Dec 31, 2016	9.20M	4.84M	110.79%
Dec 31, 2015	4.36M	841.00K	23.87%
Dec 31, 2014	3.52M	-	-
Dec 31, 2013	0	-	-
Dec 31, 2012	34.87M	26.48M	315.81%
Dec 31, 2011	8.39M	1.74M	26.26%
Dec 31, 2010	6.64M	6.25M	1,611.86%
Dec 31, 2009	388.00K	-	-
Dec 31, 2008	-	-	-
Dec 31, 2007	-	-	-
Dec 31, 2006	-	-	-
Dec 31, 2005	150.00K	-	-